
Avience Biomedicals Ltd IPO
Last updated:
Avience Biomedicals Ltd IPO Price Range is ₹196 - ₹208, with a minimum investment of ₹2,49,600 for 1200 shares per lot.
Subscription Rate
355.057x
as on 22 Jun 2026, 07:00PM IST
Minimum Investment
₹2,49,600
/ 1200 shares
IPO Status
Price Band
₹196 - ₹208
Bidding Dates
Jun 18, 2026 - Jun 22, 2026
Issue Size
₹30.24 Cr
Lot Size
600 shares
Min Investment
₹2,49,600
Listing Exchange
NSE
Avience Biomedicals Ltd IPO Application Timeline




IPO Subscription Status
as on 22 Jun 2026, 07:00PM IST
IPO subscribed over
🚀 355.057x
This IPO has been subscribed by 401.357x in the retail category and 196.774x in the QIB category.
Subscription Rate
| Total Subscription | 355.057x |
| Retail Individual Investors | 401.357x |
| Qualified Institutional Buyers | 196.774x |
| Non Institutional Investors | 427.766x |
Strengths and Risks
Strengths
Experienced Management Team and trained Employees.
Optimal Utilization of Resources.
Quality assurance and control.
Cordial relationships with our clients.
Risks
The pharmaceutical market is subject to extensive regulation and failures to comply with the existing and future regulatoryrequirements in any pharmaceutical market could expose its to litigation or other liabilities, which could adversely affectthe company reputation, business, financial condition and results of operations.
The company is dependent on certain customers for a portion of its revenues. The loss of any of its major customers dues to anyadverse development or significant reduction in business from its major customers may adversely affect the company business,financial condition, results of operations and future prospects.
The company relies on suppliers for medical devices and equipment manufacturers for its trading goods, and also faces risks in sourcingraw materials and components from third parties for the manufacturing and assembly of its medical equipment. Anydisruption in the supply of these goods or materials could adversely impact the company business, operations, and financial condition.
The company Financial Statement as Restated are prepared and signed by the Peer Review Auditor who is not Statutory Auditors ofits Company as required under the provisions of ICDR.
The company business derives a significant portion of its revenue from the trading sector, and any potential instability in this areacould pose a risk to the company overall performance.
The purchase and sale of medical devices and equipment for the company trading activities is significantly dependent on relatedparties.
Customer orders may experience delays, modifications, cancellations, or may not be fully paid, which could negativelyimpact the company business, financial condition, and operational results.
The company requires sizeable amounts of working capital for its continued operation and growth. The company inability to meet its workingcapital requirements could has a material adverse effect on the company business, results of operations and financial condition.
The company business depends on the efficient functioning of its manufacturing facilities and assembly units. Although the company has not received any product-related complaints, occasional machinery breakdowns in the past highlight the importance ofregular maintenance and operational enhancements. Any unforeseen obsolescence, damage, theft, or delays in repair couldhas an adverse impact on the company operations, cash flows, financial condition, and results.
The company import a portion of its raw material supply from China. Restrictions on or import duties relating to materials andequipment imported for the company manufacturing operations as well as restrictions on or import duties levied on its products inthe company export markets may adversely affect its business prospects, financial performance and cash flows.
How to Apply for Avience Biomedicals Ltd IPO on INDmoney
- Download the INDmoney app and complete your KYC.
- Go to INDstocks → IPO, or just search “IPO”.
- Tap on Avience Biomedicals Ltd IPO from the list of live IPOs.
- View key details like price band, lot size, and dates.
- Tap Apply Now and choose your number of lots.
- Use INDpay UPI for instant mandate tracking.
- Your funds will be blocked until the share allotment is finalized.